Magnetic resonance imaging outcomes from a phase III trial of teriflunomide. Wolinsky JS, Narayana PA, Nelson F, Datta S, O'Connor P, Confavreux C, Comi G, Kappos L, Olsson TP, Truffinet P, et al. Mult Scler. 2013 Feb 27. PMID: 23447359. Abstract CommentRecommendBookmarkWatch